TY  - JOUR

T1  - The cost-effectiveness of bosentan in the United Kingdom for patients with pulmonary arterial hypertension of WHO functional class III.

JO  - Value Health

PY  - 2009/06/25

AU  - Stevenson MD

AU  - Macdonald FC

AU  - Langley J

AU  - Hunsche E

AU  - Akehurst R

ED  - 

DO  - DOI: 10.1111/j.1524-4733.2009.00568.x

VL  - 12

IS  - 8

SP  - 1100

EP  - 1105

Y2  - 2024/10/18

ER  -